Sofosbuvir buy online. It is same Sovaldi. 

Hepcinat Tablets

Hpecinat Trade Information Minimum Order Quantity 1.00 Unit of Measure Piece/Pieces Payment Terms Paypal, Others Supply Ability As Per Requirement Per Week Delivery Time 7-15 Days Packaging Details Carton Boxes Packaging. Main Export Market(s) Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Africa Main Domestic Market All India  Export Countries Details: [...]

Product Description

 Natdac 60 Trade Information

Minimum Order Quantity  1.00 Unit of Measure Piece/Pieces
Payment Terms Paypal, Others Supply Ability As Per Requirement Per Week
Delivery Time 7-15 Days Packaging Details Carton Boxes Packaging.
Main Export Market(s) Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Africa  Main Domestic Market All India
Certifications Certified Products. New cell 3 New cell 4
Natdac 60 Export Countries Details: Countries: Russsia, Ukrain, Korea, Ajbakistan, Kajistan, Poland, USA, India, Philipines & China New cell 3 New cell 4

Hepcinat contain oral nucleotide analog inhibitor of the hepatitis C virus (HCV) polymerase. Chawla Medicos have been setting benchmarks of success in the market as a prominent organization engaged in offering Hepcinat. These are antiviral drug, used in combination with other drugs for treatment of hepatitis C. Our expert agents source Hepcinat tablets from India the trusted and certified vendors of the market. We offer these Hepcinat Tablets at affordable prices to clients.

Features:

  1. Provide a higher cure rate
  2. Low indication of side effects
  3. Effective anti viral drug

Daclatasvir 

 Hepcinat Tablets (Sofosbuvir 400 mg)-Generic Sovaldi suppliers, distributors in Delhi, India.

Brand Name: Hepcinat Tablets 

 Generic Name: Sofosbuvir 

 Strength: 400 mg 

Form: TabletsTrade 

Name: HEPCINAT 400mg Manufactured By NATCO PHARMA LIMITEDHepcinat 400mg Tab 28s Substitutes:

Hepcinat 400mg Tab 28s Substitutes:

Brand Name Company Name
Hepcinat 400mg Tab 28s Natco Pharma
Hepcvir 400mg Tab 28s Cipla
Viroclear 400mg Tablet 28s Abbott India
Sovihep 400mg Tab 28s Zydus Cadila
Myhep 400mg Tab 28s Mylan Pharmaceuticals
Sofovir 400mg Tab 28s Hetero Healthcare
Sofocure 400mg Tablet 28s Emcure Pharma
Virso 400mg Tab 28s Strides Acrolab
Resof 400mg Tab 28s Dr. Reddy

Composition: Each film coated tablet contains: Sofosbuvir equivalent to Sofosbuvir 400 mg. Sofosbuvir 400mg tablets is an antiviral drug which is used in combination with other drugs for treatment of Hepatitis C Virus (HCV) infection. Compared to previous treatments, sofosbuvir based regimens provide a higher cure rate, fewer side effects, and a two- to four-fold reduced duration of therapy. 

Mechanism of Action: - Sofosbuvir contains oral nucleotide analog inhibitor of the hepatitis C virus (HCV) polymerase. The drug is a direct-acting antiviral agent and interferes straight with the HCV lifecycle, restraining the viral replication. It can be incorporated into HCV RNA by the NS5B polymerase and acts as a chain terminator. The drug is available for oral use in the form of HEPCINAT 400mg tablets. 

Dosage and Administration: The recommended daily dose of Sofosbuvir is 400 mg tablet to be taken once daily with or without food. Sofosbuvir should be used in combination with Ribavirin or in combination with Pegylated Interferon and Ribavirin for the treatment of CHC (Chronic Hepatitis C) in adults. It is highly advisable to administer the drug under strict medical supervision and advice. 

Side Effects:Adverse events associated with the use of Sofosbuvir in combination with Ribavirin may include but are not limited to, the following

  • Fatigue 
  • Headache 

Adverse events associated with the use of Sofosbuvir in combination with Peginterferon Alfa and Ribavirin may include, but are not limited to, the following:

  • Fatigue 
  • Headache 
  • Nausea 
  • Insomnia 
  • Anemia 

Packaging: Each Bottle contains 28 tablets of Sofosbuvir 400 mg.Storage: Store at 25°C in a dry place. 

 

 

 

Natdac Tablets

Natdac 60 Trade Information Minimum Order Quantity 1.00 Unit of Measure Piece/Pieces Payment Terms Paypal, Others Supply Ability As Per Requirement Per Week Delivery Time 7-15 Days Packaging Details Carton Boxes Packaging. Main Export Market(s) Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Africa Main Domestic Market All India Certifications Certified [...]

Product Description

 Natdac 60 Trade Information

Minimum Order Quantity  1.00 Unit of Measure Piece/Pieces
Payment Terms Paypal, Others Supply Ability As Per Requirement Per Week
Delivery Time 7-15 Days Packaging Details Carton Boxes Packaging.
Main Export Market(s) Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Africa  Main Domestic Market All India
Certifications Certified Products. New cell 3 New cell 4
Natdac 60 Export Countries Details: Countries: Russsia, Ukrain, Korea, Ajbakistan, Kajistan, Poland, USA, India, Philipines & China New cell 3 New cell 4

Natdac Tablets Price in India Exporters & Suppliers Buy Online

We are identified as one of the leading organizations, engaged in offering Natdac Tablets. Our expert agents procure these tablets from the certified vendors of the market. The tablets are indicated in combination with sofosbuvir for the treatment of patient with chronic hepatitis C virus. Natdac Daclatasvir Tablets are recommended to be taken orally with or without meals. We offer these tablets at pocket friendly prices.

Features:

  1. Effective antiviral drugs 
  2. Taken orally 
  3. Longer shelf life

Daclatasvir 

 Natdac Product Description

Natdac 60 is an inhibitor of non-structural protein 5A (NS5A).Each film-coated tablet contains Daclatasvir equivalent to Daclatasvir 30 mg or 60 mg.

INDICATIONS AND USAGE

 

Natdac 60 is indicated in combination with Sofosbuvir for the treatment of patient with chronic hepatitis C virus (HCV) genotype 3 infection.

DOSAGE AND ADMINISTRATION

HCV genotype and patient population Treatment Duration
Genotype 3 without cirrhosis Daclatasvir + sofosbuvir 12 weeks  
Genotype 3 with cirrhosis Daclatasvir + sofosbuvir 24 weeks

Dose modification, interruption and discontinuation

Dose modification of Natdac 60 to manage adverse reactions is not recommended.There is no virologic treatment stopping rules that apply to the combination of Natdac 60 with sofosbuvir.

 CONTRAINDICATIONS

Hypersensitivity to the active substance or to any of the excipients Coadministration with medicinal products that strongly induce cytochrome P450 3A4 (CYP3A4) and P-glycoprotein transporter (P-gp) and thus may lead to lower exposure and loss of efficacy of Daclatasvir. These active substances include but are not limited to phenytoin, carbamazepine, oxcarbazepine, rifampicin, rifapentine, systemic dexamethasone, and the herbal product St John’s wort (Hypericum perforatum).

WARNINGS AND PRECAUTIONS

Natdac 60 must not be administered as monotherapy.DeciHeptm must be administered in combination with other medicinal products for the the treatment of chronic HCV infection. 

General

The safety and efficacy of the combination of Daclatasvir and sofosbuvir have been evaluated in a limited number of patients with cirrhosis in clinical studies. 

Decompensates liver disease 

The safety and efficacy of MyDacla 60 in the treatment of HCV infection in patients with decompensated liver disease have not been established. 

Retreatment with MyDacla 60 

The efficacy of MyDacla 60 as part of a retreatment regimen in patients with prior exposure to a NS5A inhibitor has not been established.

Pregnancy and contraception requirements 

Natdac 60 should not be used during pregnancy or in women of childbearing potential not using contraception.Use of highly effective contraception should be continued for 5 weeks after completion of Daclatasvir therapy. 

ADVERSE REACTIONS 

Adverse reactions in clinical trials.

The most common adverse reactions(>=10%) were fatigue and headache, aneamia,hot flush,nausea in subjects treated with 8, 12, or 24 weeks of Ledipasvir + Sofosbuvir. 

DRUG INTERACTIONS 

Contraindications of concomitant use 

Natdac 60  is contraindication in combination with medicinal products that strongly induce CYP3A4 and P-gp,e.g. phenytoin,carbamazepine,oxcarbazepine,rifampicin,rifabutin,rifapen-tine,systemic dexamethasone, and the herbal product St John’s wort (Hypericum perforatum), and thus may lead to lower exposure and loss of efficacy of Daclatasvir. 

Packaging: Each Bottle contains 28 tablets of Daclatasvir 60 mg.Storage: Store at 25°C in a dry place.